drugset / Trial / NCT02623868
Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess the pharmacokinetic/pharmacodynamic characteristics and safety/tolerability to CKD-519 new formulation in healthy male subjects.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ROCACETRAPIB | Small molecule | 50 mg | — |
| Subject | ROCACETRAPIB | Small molecule | 100 mg | — |